ABIOMED Inc (ABMD) Financials

$381.02

$0.00 (0.00%)

As on 23-Dec-2022 09:30EDT

Market cap

$17,181 Mln

Revenue (TTM)

$1,074 Mln

P/E Ratio

65.4

P/B Ratio

11.1

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Operating Revenue	1,074.10	1,031.75	847.52	840.88	769.43	593.75
Cost of Revenue	200.59	188.16	161.91	151.31	129.57	98.58
Gross Profit	873.51	843.60	685.62	689.58	639.87	495.17
Operating Expenses	619.40	586.89	456.06	440.36	415.05	338.03
Operating Profit (EBIT)	253.61	140.72	229.56	249.22	224.81	157.14
Other Income	87.55	49.84	58.66	7.61	38.55	3.30
Profit before Tax	341.16	190.56	288.22	256.83	263.36	160.44
Provision for Tax	74.40	54.06	62.70	53.82	4.34	48.27
Profit after Tax (Net Income)	266.76	136.51	225.53	203.01	259.02	112.17
Minority Interest	--	--	--	--	--	--
Consolidated Profit	266.76	136.51	225.53	203.01	259.02	112.17

Liabilities ($ Mln)	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Shareholder's Funds	1,539.79	1,503.33	1,329.68	1,065.47	936.89	689.52
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	22.70	31.61	35.72	19.11	11.46	12.17
Current Liabilities	134.06	138.46	128.97	131.89	106.00	84.68
Total Liabilities	1,831.29	1,673.39	1,494.36	1,216.46	1,054.35	786.38

Assets ($ Mln)	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Non-Current Assets	633.75	696.92	706.39	580.60	377.15	292.10
Current Assets	1,062.80	976.47	787.97	635.86	677.20	494.27
Total Assets	1,830.60	1,673.39	1,494.36	1,216.46	1,054.35	786.38
Total Debt*	--	--	--	--	--	--
Net Current Assets	928.74	838.02	659.00	503.98	571.20	409.59

Cashflow ($ Mln)	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Cash From Operating Activities	--	285.39	274.58	314.92	252.20	192.55
Cash Flow from Investing Activities	--	-380.99	-223.34	-125.46	-116.46	-180.76
Cash from Financing Activities	--	-2.20	-8.07	-117.72	-55.78	-9.14
Net Cash Inflow / Outflow	--	-99.89	40.37	71.32	78.05	3.94

Financials Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Adjusted EPS ($)	5.80	2.97	4.90	4.41	5.63	2.44
Cash EPS ($)	--	3.58	5.43	4.86	5.94	2.68
Adjusted Book Value ($)	--	32.68	28.91	23.16	20.37	14.99
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	6.20	5.97	6.85	5.48	4.19
Free Cash Flow per Share ($)	--	5.43	4.81	5.89	4.53	2.97

Profitability Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
ROCE (%)	--	9.64	18.83	20.28	31.85	19.37
ROE (%)	17.53	9.64	18.83	20.28	31.85	19.65
ROA (%)	15.35	8.62	16.64	17.88	28.14	16.78
EBIT Margin (%)	40.54	23.30	34.01	30.54	34.23	27.02
Net Margin (%)	22.96	12.62	24.89	23.93	32.06	18.79
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Revenue Growth (%)	10.32	0.22	0.01	0.09	0.30	0.33
EBIT Growth (%)	105.23	-16.59	12.22	-2.48	64.15	75.64
Net Profit Growth (%)	78.85	-39.47	11.09	-21.62	130.91	115.23
EPS Growth (%)	79.56	-0.39	0.11	-0.22	1.31	1.11
Book Value Growth (%)	11.21	--	--	--	--	--

Valuation Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Price / Earnings	65.36	111.62	65.01	32.89	50.72	119.33
Price / Book Value	11.13	10.14	11.03	6.27	14.02	19.41
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	57.94	53.93	45.08	22.49	45.57	75.96
Close Price ($)	245.66	331.24	318.73	145.16	285.59	290.99
High Price ($)	379.30	379.30	387.40	293.44	459.75	304.28
Low Price ($)	219.85	261.27	140.14	119.01	272.17	117.37
Market Cap ($ Cr)	17,180.65	--	--	--	--	--

Solvency Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	7.93	7.05	6.11	4.82	6.39	5.84
Quick Ratio	7.17	6.37	5.48	4.14	5.63	5.24
Interest Coverage	4.62	4.82	--	--	--	--

Operating Efficiency Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18
Debtors to sales (%)	8.80	8.78	11.47	10.07	11.80	11.79
Asset Turnover	0.62	0.65	0.63	0.74	0.84	0.89
Receivable days	--	33.24	39.18	38.11	38.17	38.16
Inventory Days	--	169.89	193.05	206.43	184.85	157.72
Payable days	--	68.12	76.27	78.41	78.58	81.85
Cash Conversion Cycle	--	135.01	155.96	166.13	144.44	114.02

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)